Rangwala Reshma
SEC CIK 1825322 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | EVP, Chief Medical Off | 56.8K | — | $144.2K | 17 | 2022-04-29 | 2026-05-14 |
Most active insiders at KPTI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Paulson Richard A. | Pres, CEO, Dir | — | $137.2K |
| 2 | Poulton Stuart | EVP, Chief Development Off | — | $56.4K |
| 3 | Rangwala Reshma | EVP, Chief Medical Off | — | $55.6K |
| 4 | Cheng Sohanya Roshan | EVP, Chief Commercial Off | — | $46.4K |
| 5 | Mano Michael | SVP, GC, Sec | — | $35.7K |
| 6 | Macomber Lori | EVP, CFO, Treas | — | $10.2K |
| 7 | Abate Kristin | CAO | — | $10.0K |
| 8 | Su Zhen | Dir | — | — |
| 9 | Oliger Christy J. | Dir | — | — |
| 10 | Schor Chen | Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 16:07 | 2026-05-13 | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | EVP, Chief Medical Off | A - Grant | $0.00 | +947 | 57.2K | +2% | $0 | |
| 2026-05-15 16:07 | 2026-05-14 | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | EVP, Chief Medical Off | S - Sale | $9.50 | -408 | 56.8K | -0.7% | -$3,876 | |
| 2026-04-22 16:03 | 2026-04-21 | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | EVP, Chief Medical Off | S - Sale | $8.94 | -449 | 56.3K | -0.8% | -$4,014 | |
| 2026-03-03 | 2026-03-02 | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | EVP, Chief Medical Off | S - Sale | $9.41 | -5,066 | 56.7K | -8% | -$47.7K | |
| 2026-02-03 | 2026-01-31 | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | EVP, Chief Medical Off | A - Grant | $0.00 | +32.4K | 61.8K | +110% | $0 | |
| 2025-09-16 | 2025-09-15 | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | EVP, Chief Medical Off | S - Sale | $6.43 | -408 | 29.4K | -1% | -$2,623 | |
| 2025-09-16 | 2025-09-12 | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | EVP, Chief Medical Off | A - Grant | $0.00 | +945 | 29.8K | +3% | $0 | |
| 2025-04-24 | 2025-04-23 | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | EVP, Chief Medical Off | S - Sale | $6.17 | -419 | 28.9K | -1% | -$2,585 | |
| 2025-03-06 | 2025-03-04 | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | EVP, Chief Medical Off | S - Sale | $6.29 | -3,587 | 29.3K | -11% | -$22.6K | |
| DM | 2025-03-04 | 2025-02-28 | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | EVP, Chief Medical Off | A - Grant | $0.00 | +9,999 | 28.3K | +55% | $0 |
| 2024-04-23 | 2024-04-22 | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | EVP, Chief Medical Off | S - Sale | $1.17 | -6,789 | 342.9K | -2% | -$7,943 | |
| M | 2024-03-04 | 2024-02-29+ | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | EVP, Chief Medical Off | S - Sale | $1.18 | -21.6K | 349.7K | -6% | -$25.5K |
| 2024-02-29 | 2024-02-28 | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | EVP, Chief Medical Off | A - Grant | $0.00 | +199.0K | 371.4K | +115% | $0 | |
| 2024-01-25 | 2024-01-24 | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | EVP, Chief Medical Off | A - Grant | $0.00 | +14.2K | 172.4K | +9% | $0 | |
| M | 2023-04-24 | 2023-04-20 | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | EVP, Chief Medical Off | S - Sale | $4.05 | -6,770 | 158.2K | -4% | -$27.4K |
| 2023-03-02 | 2023-02-28 | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | EVP, Chief Medical Off | A - Grant | $0.00 | +100.0K | 165.0K | +154% | $0 | |
| D | 2022-05-02 | 2022-04-29 | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | EVP, Chief Medical Off | A - Grant | $0.00 | +65.0K | 65.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations